Virtual fragment screening on GPCRs: a case study on dopamine D3 and histamine H4 receptors.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European journal of medicinal chemistry

• Publication date

  2014-04-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2014.02.034PMID 24607587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fragments to link. A multiple docking strategy for second site binders

  2013cited by this paper
• Parallel Screening of Low Molecular Weight Fragment Libraries

  2013cited by this paper
• How are fragments optimized? A retrospective analysis of 145 fragment optimizations.

  2013cited by this paper
• The Impact of Molecular Dynamics Sampling on the Performance of Virtual Screening against GPCRs

  2013cited by this paper
• Fragment-Based Drug Discovery Using a Multidomain, Parallel MD-MM/PBSA Screening Protocol

  2013cited by this paper
• Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story.

  2013cited by this paper
• Computational fragment-based screening using RosettaLigand: the SAMPL3 challenge

  2012cited by this paper
• Exploring protein flexibility: incorporating structural ensembles from crystal structures and simulation into virtual screening protocols.

  2012cited by this paper
• Fragment-based lead discovery grows up

  2012cited by this paper
• Thermodynamics of Fragment Binding

  2012cited by this paper
• Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints

  2012cited by this paper
• Virtual fragment screening: exploration of MM-PBSA re-scoring

  2012cited by this paper
• Lead generation and examples opinion regarding how to follow up hits.

  2011cited by this paper
• Docking performance of fragments and druglike compounds.

  2011cited by this paper
• Molecular Determinants of Ligand Binding to H4R Species Variants

  2010cited by this paper
• Virtual Fragment Docking by Glide: a Validation Study on 190 Protein-Fragment Complexes

  2010cited by this paper
• Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide

  2009cited by this paper
• Managing protein flexibility in docking and its applications.

  2009cited by this paper
• Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

  2008cited by this paper
• Novel procedure for modeling ligand/receptor induced fit effects.

  2006cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• Scalable molecular dynamics with NAMD

  2005cited by this paper
• The Amber biomolecular simulation programs

  2005cited by this paper
• Representing receptor flexibility in ligand docking through relevant normal modes.

  2005cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment

  2001cited by this paper

• Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures

  2024cites this paper
• Homology Modeling of the G Protein-Coupled Receptors.

  2023cites this paper
• Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds

  2023influential citation
• Using novel click chemistry algorithm to design D3R inhibitors as blood-brain barrier permeants.

  2023cites this paper
• Discovery of P2Y2 Receptor Antagonist Scaffolds through Virtual High-Throughput Screening

  2022cites this paper
• Receptor Cavity-Based Approach Combined with Autodock Protocol for the Screening of Antiviral Compounds from Streptomyces sp.

  2022cites this paper
• Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?

  2021cites this paper
• Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery

  2021influential citation
• Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?

  2021cites this paper
• A Focus on Unusual ECL2 Interactions Yields β2‐Adrenergic Receptor Antagonists with Unprecedented Scaffolds

  2020cites this paper
• Computer-aided GPCR drug discovery

  2020cites this paper
• Efficiency of Homology Modeling assisted Molecular Docking in G-protein coupled receptors.

  2020cites this paper
• Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity

  2020cites this paper
• Multi-Dimensional Screening Strategy for Drug Repurposing with Statistical Framework—A New Road to Influenza Drug discovery

  2019cites this paper
• E-pharmacophore hypothesis strategy to discover potent inhibitor for influenza treatment

  2019cites this paper
• Use of molecular dynamics simulations in structure-based drug discovery.

  2019cites this paper
• Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.

  2018cites this paper
• Molecular dynamics simulations and novel drug discovery

  2018cites this paper
• Computational Methods for GPCR Drug Discovery

  2018cites this paper
• Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design

  2018cites this paper
• Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor

  2018cites this paper
• Shining Light on Molecular Mechanism for Odor-selectivity of CNT-immobilized Olfactory Receptor

  2018cites this paper
• Energy Based Pharmacophore Modelling and Docking Studies for Determining Potent Inhibitor Against M2 Proton Channel of Influenza Virus

  2018cites this paper
• Clavis Aurea? Structure-enabled approaches of identifying and optimizing GPCR ligands

  2017cites this paper
• Structure-Based Discovery of GPCR Ligands from Crystal Structures and Homology Models

  2017cites this paper
• Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors

  2017cites this paper
• Modeling and Design for Membrane Protein Targets

  2017cites this paper
• Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor

  2017cites this paper
• Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening.

  2017cites this paper
• Ligand Discovery for a Peptide-Binding GPCR by Structure-Based Screening of Fragment- and Lead-Like Chemical Libraries.

  2017cites this paper
• In silico modeling techniques for predicting the tertiary structure of human H4 receptor.

  2016cites this paper
• Computational methods for studying G protein-coupled receptors (GPCRs).

  2016cites this paper
• Docking Methodologies and Recent Advances

  2016cites this paper
• Fragment Screening in Complex Systems

  2016cites this paper
• Structural studies of G protein‐coupled receptors

  2016cites this paper
• 1,4‑双取代‑1,2,3,6‑四氢吡啶类化合物、其制备方法、药物组合物及其应用

  2016cites this paper
• Monocyclic and Fused Azines and Azoles as Histamine H4 Receptor Ligands.

  2016cites this paper
• Function-specific virtual screening for GPCR ligands using a combined scoring method

  2016cites this paper
• Computer-Aided Drug Discovery

  2016cites this paper
• Structure-based discovery and binding site analysis of histamine receptor ligands

  2016cites this paper
• (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.

  2015cites this paper
• Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models.

  2015cites this paper
• A Simplified Schematic Representation of Cell-based High-Throughput Screening ( HTS ) , Structure-based and Sensor-based Ligand Discovery Approaches

  2015cites this paper
• Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT3A, Histamine H1, and Histamine H4 Receptors

  2015cites this paper
• Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures.

  2015cites this paper
• VU Research Portal In silico Medicinal

  2015cites this paper
• Open challenges in structure-based virtual screening: Receptor modeling, target flexibility consideration and active site water molecules description.

  2015cites this paper
• A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets

  2015cites this paper
• Docking and Virtual Screening Strategies for GPCR Drug Discovery.

  2015cites this paper
• Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.

  2015cites this paper
• G Protein-Coupled Receptors in Drug Discovery

  2015cites this paper
• Emerging Approaches to GPCR Ligand Screening for Drug Discovery.

  2015cites this paper
• Discovery of trace amine-associated receptor 1 ligands by molecular docking screening against a homology model

  2015cites this paper
• Computational Fragment-Based Drug Design

  2015cites this paper
• A computational perspective on drug discovery and signal transduction mechanism of dopamine and serotonin receptors in the treatment of schizophrenia.

  2014cites this paper
• Discovery of GPCR ligands for probing signal transduction pathways

  2014cites this paper
• Ligand Efficiency-Based Support Vector Regression Models for Predicting Bioactivities of Ligands to Drug Target Proteins

  2014cites this paper